Cargando…
二线方案治疗98例复发难治弥漫大B细胞淋巴瘤的疗效及预后分析
OBJECTIVE: To evaluate the efficacy and prognostic factors of second-line regimens for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). METHODS: A retrospective analysis was performed in 98 patients with relapsed/refractory DLBCL who were treated with salvage regimens in Rui...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342960/ https://www.ncbi.nlm.nih.gov/pubmed/28655095 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.06.009 |
Ejemplares similares
-
利妥昔单抗联合二线方案治疗七例复发难治性霍奇金淋巴瘤患者疗效观察
Publicado: (2015) -
乙型肝炎病毒感染对复发难治性弥漫大B细胞淋巴瘤疗效及预后的影响
Publicado: (2018) -
RCDOP方案治疗87例弥漫大B细胞淋巴瘤患者疗效分析
Publicado: (2018) -
CAG预激方案治疗复发难治成人急性淋巴细胞白血病的疗效观察
Publicado: (2018) -
DICE方案治疗97例复发/难治非霍奇金淋巴瘤患者的疗效及生存分析
Publicado: (2016)